These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 15851492)
1. COX-2 inhibitors still eyed for cancer prevention. Thompson CA Am J Health Syst Pharm; 2005 May; 62(9):890, 894. PubMed ID: 15851492 [No Abstract] [Full Text] [Related]
2. Tailoring arthritis therapy in the wake of the NSAID crisis. Olsen NJ N Engl J Med; 2005 Jun; 352(25):2578-80. PubMed ID: 15972863 [No Abstract] [Full Text] [Related]
3. COX-2 inhibitors and cardiovascular toxicity: a class effect? Laible B S D J Med; 2005 Mar; 58(3):93-4. PubMed ID: 15794479 [No Abstract] [Full Text] [Related]
4. COX-2 inhibitors--a lesson in unexpected problems. Drazen JM N Engl J Med; 2005 Mar; 352(11):1131-2. PubMed ID: 15713947 [No Abstract] [Full Text] [Related]
5. A tale of two coxibs. Hegmann T JAAPA; 2005 Mar; 18(3):14, 17. PubMed ID: 15789666 [No Abstract] [Full Text] [Related]
6. COX-2 inhibitors: cancer prevention or cardiovascular risk? Senior K Lancet Oncol; 2005 Feb; 6(2):68. PubMed ID: 15704289 [No Abstract] [Full Text] [Related]
7. The safety of the perioperative administration of cyclooxygenase-2 inhibitors for post-surgical pain. Reuben SS Acta Anaesthesiol Scand; 2005 Mar; 49(3):424; author reply 425. PubMed ID: 15752415 [No Abstract] [Full Text] [Related]
8. Drug safety. FDA panel urges caution on many anti-inflammatory drugs. Couzin J Science; 2005 Feb; 307(5713):1183-5. PubMed ID: 15731414 [No Abstract] [Full Text] [Related]
9. The COX-2 inhibitors--an update. Furberg CD Am Heart J; 2006 Aug; 152(2):197-9. PubMed ID: 16875896 [No Abstract] [Full Text] [Related]
17. Concerns about COX-2 painkillers. They're easier on the stomach, potentially harder on your heart. Heart Advis; 2002 Jan; 5(1):2. PubMed ID: 16145759 [No Abstract] [Full Text] [Related]
18. The pain game. Wadman M Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159 [No Abstract] [Full Text] [Related]
19. Patient characteristics associated with outpatient prescriptions for nabumetone and oxaprozin versus celecoxib and rofecoxib. Brinker A; Nourjah P Am J Health Syst Pharm; 2005 Apr; 62(7):739-43. PubMed ID: 15790802 [No Abstract] [Full Text] [Related]
20. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG; Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]